nCOVID-19
10y
Better.Be.First.
Fast patient
Proof of concept trials

PROOF OF CONCEPT TRIALS

proof of concept trials

ARENSIA delivers high degree of scientific and logistical expertise for Phase I/Ib/IIa and PROOF OF CONCEPT patient studies.

MORE

PHASE I SPECIAL POPULATIONS

phase i special populations

ARENSIA offers exceptional fast recruitment rates for renal and hepatic impaired patients.

MORE

REGULATORY PROCESS

regulatory process

ARENSIA has the know-how to successfully manage the regulatory process in various Eastern European countries.

MORE

FIRST TWO COVID-19 TRIALS APPROVED IN MOLDOVA WITH PRIORITY REVIEW!

HOME · NEWS · FIRST TWO COVID-19 TRIALS APPROVED IN MOLDOVA WITH PRIORITY REVIEW!

On July 21, Moldovan Agency of Medicines and Medical Devices (AMDM, Agentia Medicamentelor si Dispozitivelor Medicale) has approved with priority review the first two clinical trials on COVID-19. The studies will include patients with moderate and/or severe condition.

Both clinical trials are conducted at the initiative of ARENSIA Exploratory Medicine in collaboration with the Republican Clinical Hospital "Timofei Moşneaga" with principal investigator Prof. Dr. Victor Cojocaru, Director of the Clinic for Anesthesiology and Intensive Therapy.

The first clinical trial will study a novel drug for the treatment of acute lung injury associated with COVID-19.

The second trial will study a novel investigational product, which has shown a promising antiviral activity against several human coronaviruses.

“It is a privilege to us and an opportunity as well that these large pharmaceutical companies dedicated to research, development and production of medicines from USA, EU and Canada have chosen the Republic of Moldova, along with other major countries, to conduct these clinical trials, with the purpose of development of effective drugs for the treatment of COVID-19 infection, from which our citizens will benefit too", said Mr. Eremei Priseajniuc, General Manager of AMDM.

“This is just the beginning!”, assures Dr. Nelea Ghicavîi, Country Manager of ARENSIA Exploratory Medicine Moldova, “At ARENSIA, we are working intensely on bringing more innovative treatments to Moldova.”

Claudia Hesselmann, CEO of ARENSIA Exploratory Medicine GmbH, Germany, highlights the importance of the contribution of AMDM, and in general of the Ministry of Health of the Republic of Moldova to attracting important research projects to Moldova: “The authorities of Moldova offer outstanding support for high quality clinical research. The speed of action of the Moldovan authorities under the urgency of COVID-19 is unrivalled!”

https://amdm.gov.md/ro/article/studii-clinice-destinate-tratamentului-infecției-covid-19-aprobate-în-premieră-de-agenția

22.07.2020
VIDEO INTRO

We use technologies, such as cookies, and process personal data, such as IP addresses and cookie identifiers, to personalise content based on your interests, measure the performance of our content, and derive insights about the audiences who saw it. You can read more about our Cookie Policy here.

I accept I refuse